Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the market
Please see updated information from the FDA concerning the phase-out of CFC inhalers
Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the market.
The current version will no longer be sold by the end of 2011 as part of the ban on CFC propellants. You'll probably get an HFA version by then.
This brings up the controversy as to whether asthma inhalers should be available OTC.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote